Our leadership team brings together the unique talents of world-leading physicians and scientists. We have dedicated years of research to developing safe, non-invasive alternatives to traditional testing methods. We all share the same vision to empower patients and clinicians through a greater understanding of liver disease, and we aim to create a culture of patient-centric innovation throughout the organization.
Interim CEO
Dr Rexford Newbould
Chief Technical Officer
Dr Matthew Robson
President Pharma Solutions
Marija Mavar
VP People Success
Mehru Asad
SVP Investor Relations
Amanda Chin
SVP Commercial Operations